Health
Vaccine experts meeting over clot report – The Islander
A Melbourne man’s rare blood clotting disorder, likely linked to the AstraZeneca COVID-19 vaccine, will not affect its rollout to Australians. The Therapeutic……
A Melbourne man’s rare blood clotting disorder, likely linked to the AstraZeneca COVID-19 vaccine, will not affect its rollout to Australians.
The Therapeutic Goods Administration and Australian Technical Advisory Group on Immunisation met on Saturday morning and Acting Chief Medical Officer Michael Kidd said no changes to the AstraZeneca rollout were recommended.
He said it was likely, given similarities with rare overseas cases, that the man’s clotting disorder was related to him receiving the…
-
Noosa News21 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business20 hours agoDicker Data rides the AI trend to double digit growth
-
Business24 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy
-
Noosa News21 hours agoBob Katter threatens Channel 9 journalist for asking question on family heritage